These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 25664464

  • 1. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease.
    Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group.
    Neuropsychology; 2015 Jul; 29(4):571-81. PubMed ID: 25664464
    [Abstract] [Full Text] [Related]

  • 2. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P, AIBL Research Group.
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [Abstract] [Full Text] [Related]

  • 3. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease.
    Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC, AIBL Research Group.
    Alzheimers Dement; 2014 Nov; 10(6):743-751.e1. PubMed ID: 24589436
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
    Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA, Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Research Group.
    Int Psychogeriatr; 2013 Aug; 25(8):1307-15. PubMed ID: 23693133
    [Abstract] [Full Text] [Related]

  • 5. Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer's disease including pre-mild cognitive impairment.
    Seo EH, Kim H, Choi KY, Lee KH, Choo IH.
    J Affect Disord; 2017 Aug 01; 217():24-28. PubMed ID: 28380342
    [Abstract] [Full Text] [Related]

  • 6. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE, Lim YY, Jaeger J, Ames D, Lautenschlager NT, Robertson J, Pietrzak RH, Snyder PJ, Villemagne VL, Rowe CC, Masters CL, Maruff P.
    J Alzheimers Dis; 2018 Aug 01; 65(3):977-988. PubMed ID: 30103330
    [Abstract] [Full Text] [Related]

  • 7. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.
    Vannini P, Amariglio R, Hanseeuw B, Johnson KA, McLaren DG, Chhatwal J, Pascual-Leone A, Rentz D, Sperling RA.
    Neuropsychologia; 2017 May 01; 99():343-349. PubMed ID: 28385579
    [Abstract] [Full Text] [Related]

  • 8. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing.
    Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA.
    J Alzheimers Dis; 2014 May 01; 40(3):551-61. PubMed ID: 24496075
    [Abstract] [Full Text] [Related]

  • 9. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI.
    J Alzheimers Dis; 2015 May 01; 48(4):1095-107. PubMed ID: 26402083
    [Abstract] [Full Text] [Related]

  • 10. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL, AIBL Research Group.
    Lancet Neurol; 2016 Sep 01; 15(10):1044-53. PubMed ID: 27450471
    [Abstract] [Full Text] [Related]

  • 11. Cognitive Complaints in Memory Clinic Patients and in Depressive Patients: An Interpretative Phenomenological Analysis.
    Miebach L, Wolfsgruber S, Frommann I, Fließbach K, Jessen F, Buckley R, Wagner M.
    Gerontologist; 2019 Mar 14; 59(2):290-302. PubMed ID: 29325011
    [Abstract] [Full Text] [Related]

  • 12. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment.
    Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D.
    Age Ageing; 2015 Nov 14; 44(6):1012-9. PubMed ID: 26452663
    [Abstract] [Full Text] [Related]

  • 13. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P, Australian Imaging, Biomarkers, and Lifestyle Research Group.
    JAMA Psychiatry; 2015 Mar 14; 72(3):284-91. PubMed ID: 25629787
    [Abstract] [Full Text] [Related]

  • 14. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
    Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P.
    J Alzheimers Dis; 2015 Mar 14; 43(2):677-86. PubMed ID: 25114076
    [Abstract] [Full Text] [Related]

  • 15. Different Cognitive Complaint Profiles in Memory Clinic and Depressive Patients.
    Miebach L, Wolfsgruber S, Frommann I, Buckley R, Wagner M.
    Am J Geriatr Psychiatry; 2018 Apr 14; 26(4):463-475. PubMed ID: 29224729
    [Abstract] [Full Text] [Related]

  • 16. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, AIBL Research Group.
    Brain; 2014 Jan 14; 137(Pt 1):221-31. PubMed ID: 24176981
    [Abstract] [Full Text] [Related]

  • 17. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    Goldstein FC, Loring DW, Thomas T, Saleh S, Hajjar I.
    J Alzheimers Dis; 2019 Jan 14; 72(2):507-514. PubMed ID: 31594225
    [Abstract] [Full Text] [Related]

  • 18. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.
    Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A.
    J Alzheimers Dis; 2020 Jan 14; 77(3):1057-1065. PubMed ID: 32925048
    [Abstract] [Full Text] [Related]

  • 19. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
    Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P.
    J Alzheimers Dis; 2013 Jan 14; 33(4):1167-76. PubMed ID: 23160011
    [Abstract] [Full Text] [Related]

  • 20. Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?
    Mendes T, Cardoso S, Guerreiro M, Maroco J, Silva D, Alves L, Schmand B, Gerardo B, Lima M, Santana I, de Mendonça A.
    J Alzheimers Dis; 2019 Jan 14; 70(4):1103-1111. PubMed ID: 31306132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.